To clarify conflicting reports on the incidence of breast cancer in SSc, a research team studies the development of breast cancer in SSc patients and compares them with a nonscleroderma cohort of breast cancer patients.
Three Cleveland Clinic cardiac surgeons explain why the answer is “yes” in the wake of a new JACC study showing just how much volume and experience matter in mitral valve surgery.
Orthopaedics accounts for 20 to 30 percent of healthcare dollars spent in the U.S. That’s one impetus for Cleveland Clinic’s Orthopaedic Surgery Department to develop its own robust system for accurately measuring outcomes.
Which patients with submassive embolism would benefit from thrombolysis, and which patients require only anticoagulant therapy? The answer lies in finding the balance between the potential benefit of thrombolytic therapy — preventing death or hemodynamic collapse — and the numerically low but potentially catastrophic risk of intracranial bleeding.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Encouraged by Nurses Week 2017 and the ANA’s call for nurses to focus on self-nurturing, ECNO Kelly Hancock reminds nurse leaders of another necessary form of nurturing – nurturing the next generation.
Findings from a large retrospective data set show that the first follow-up MRI after stereotactic radiosurgery for brain metastasis can be an important tool for predicting long-term tumor control.
A serious fall can be life threatening for people over age 65. To help patients avoid future falls, a special clinic at Cleveland Clinic is dedicated to doing in-depth fall risk assessments.
Newly approved treatment for prostate cancer helps men keep the gland and maintain sexual/biological function, while delivering same outcomes as radiation therapy with less treatment burden.
Physician stress and burnout are real. Find out what Conor Delaney, MD, PhD, Chair of the Digestive Disease & Surgery Institute, and his team are doing to fight back in our “The Short Answer” series.
A Cleveland Clinic researcher thinks we may already have all the drugs we need to treat most cancers. We just need to be smarter about how we use them.